Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 622 of 6351
-
Drop of blood could spot deadly poison in minutes
Diagnosis Recruiting nowMethanol poisoning is a serious issue, particularly in low- and middle-income countries (LMICs), where outbreaks can devastate communities. Diagnosing methanol poisoning is challenging because its symptoms mimic many other conditions, and traditional diagnostic methods require ex…
Sponsor: University of Edinburgh • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New drug trial aims to boost survival in severe lung failure patients
Disease control Recruiting nowThis is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design. Cohort…
Phase 2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Biomarker-Guided cocktail aims to slow kidney failure
Disease control Recruiting nowOver 800 million people worldwide suffer from chronic kidney disease (CKD), which is associated with a high individual disease burden for those affected, multiple secondary diseases, frequent doctor contacts, and hospitalizations, but also outstanding costs for the health system …
Phase 4 • Sponsor: Peter Rossing • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for stomach cancer: targeted drug combo under study
Disease control Recruiting nowThe primary objective is to validate, throughout a national real-world study, the efficacy and safety of Zolbetuximab combined with FOLFOX or XELOX regimens. Specific clinical issues will be studied by pre-planned subgroup analyses, addressing practical clinical needs which have …
Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New eye drops aim to ease painful corneal scratches in rare skin disease
Disease control Recruiting nowKB803-EYE-01 is a Phase 3 double-blind, randomized, placebo-controlled, crossover study to evaluate the safety and efficacy of KB803 versus matched placebo in pediatric and adult subjects with recurrent corneal abrasions due to dystrophic epidermolysis bullosa (DEB).
Phase 3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy takes on bulky tumors
Disease control Recruiting nowStudy Objectives Primary Objective:To evaluate the safety of SFRT followed by hypofractionated/conventional fractionated radiotherapy combined with Iparomlimab and Tuvonralimab Injection in relapsed/refractory bulky solid tumors. Secondary Objectives:To assess efficacy (objectiv…
Phase 2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Two new drugs join forces with chemo to tackle tough lymphoma
Disease control Recruiting nowThis study is developed by the investigator and is a, phase I, single arm, clinical trial that will enroll subjects with untreated diffuse large B-cell lymphoma (DLCBL) at high risk for poor outcome. The types of treatments given will be shared with participants. The aims are: …
Phase 1 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Engineered immune cells take aim at childhood cancer
Disease control OngoingThis is a first in human dose escalation trial to determine the safety of administering PHOX2B PC-CAR T cells in patients with advanced, high-risk neuroblastoma.
Phase 1 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug aims to halt lung decline in scarred lungs
Disease control OngoingThe goal of this clinical trial is to learn if the investigational drug CAL101 can help prevent further decline in lung function in adults with Idiopathic Pulmonary Fibrosis. Researchers will compare CAL101 with placebo to compare change from baseline in forced vital capacity (F…
Phase 2 • Sponsor: Calluna Pharma AS • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Immune cell reprogramming offers hope for stubborn arthritis and Sjogren's
Disease control OngoingA study to assess safety, cellular kinetics and exploratory efficacy of rapcabtagene autoleucel in rheumatoid arthritis and Sjogren's disease
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug aims to cut dangerous COPD attacks in half
Disease control Recruiting nowDepemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Cell injection aims to slow vision loss in rare eye disease
Disease control OngoingThis study evaluates the safety of a single injection of jCell (famzeretcel) comprising 6.0 million (6.0M) retinal progenitor cells over a six-month study period in a cohort of adult subjects with RP. Additionally, changes in visual function will be evaluated at six months betwee…
Phase 2 • Sponsor: jCyte, Inc • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New mesh device could seal brain aneurysms, avoid surgery
Disease control Recruiting nowThe objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unrup…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Experimental combo aims to control MDS without transplant
Disease control Recruiting nowThis study aims to evaluate the safety and efficacy of a Venetoclax and hypomethylating agent-based regimen combined with infusion of HLA-mismatched donor G-CSF mobilized peripheral blood mononuclear cells (GPBMC) in patients with intermediate-risk and higher myelodysplastic synd…
Phase 2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Dogs sniff out bladder cancer in urine samples
Diagnosis Recruiting nowThe aim of this study is to estimate the sensitivity of olfactory detection of urothelial carcinomas of the bladder in urine samples by assistance dogs trained in this practice.
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Jail-to-Community opioid treatment: monthly shot vs. daily pill
Disease control Recruiting nowThis study is an open label randomized controlled trial of extended-release buprenorphine (BRIXADI, XR-B) vs. sublingual buprenorphine (SL-B) in a large metropolitan jail. An open-label design will randomly assign 240 adults with moderate-to-severe OUDs who are soon-to-be-release…
Phase 3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug aims to tame overactive thyroid without lifelong pills
Disease control Recruiting nowThis is a multi-center, global, randomized, double-blind, placebo-controlled Phase 2b study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment.
Phase 2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Sound waves boost chemo attack on tough pancreatic tumors
Disease control Recruiting nowThe purpose of the study is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic Cancer.
Phase 2 • Sponsor: EXACT Therapeutics AS • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can a quick cholesterol shot boost stroke recovery?
Disease control Recruiting nowEAST-LDL is a prospective, multicenter, randomized, open-label clinical trial with blinded endpoint assessment evaluating whether early intensive lipid lowering with the PCSK9 inhibitor recaticimab, administered before endovascular therapy, improves functional outcome in patients…
Phase 3 • Sponsor: Shanghai East Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Repairing lungs from within: stem cells harvested from Patients' own airways tested for scarring disease
Disease control Recruiting nowThis clinical trial evaluates the safety and efficacy of REGEND001, an autologous bronchial basal layer stem cell therapy, in patients with interstitial lung disease (ILD). The treatment involves harvesting the patient's own stem cells (expressing KRT5/P63 markers), expanding the…
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC